Stay updated on Comparing Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Uproleselan in AML Clinical Trial page.

Latest updates to the Comparing Uproleselan in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check18 days agoChange DetectedA site-wide NIH banner announces that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.6%

- Check24 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision label v3.6.6 was added to the history and the previous revision v3.6.5 was removed, updating the record's revision trail.SummaryDifference0.1%

Stay in the know with updates to Comparing Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Uproleselan in AML Clinical Trial page.